Erratum to: SHINBARO, a new herbal medicine with multifunctional mechanism for joint disease: First therapeutic application for the treatment of osteoarthritis

Lee, Sung-Yeol; Kwon, Hyoung-Keun; Lee, Sun-Mee

doi:10.1007/s12272-012-0421-3

Cited by 8 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Shinbaro pharmacopuncture is pharmacopuncture using GCSB-5 (Acanthopanacis Cortex, Achyranthis Radix, Saposhnikoviae Radix, Cibotii Rhizoma, Glycine Semen Nigra, Eucommiae Cortex) as the main component [30], which has anti-inflammatory effects (lowering iNOS, COX-2, TNF-α, and mRNA expression), and has a pain relieving effect by increasing the pain threshold [31]. Shinbaro pharmacopuncture also has a nerve regeneration effect [32].…”

Section: Discussionmentioning

confidence: 99%

Analysis of Research Trends in Korean Medicine Treatment for Guillain-Barre Syndrome in Korea

Jang

Kim

et al. 2022

J Acupunct Res

View full text Add to dashboard Cite

This review aimed to analyze Korean medicine treatment (KMT) methods used for Guillain-Barre syndrome (GBS) in studies from January 1, 2010, to December 21, 2021. Five online databases (KISS, SCIENCEON, DBpia, RISS, KMbase) were searched for GBS-related studies. A total of 14 case reports were selected. Various treatment methods for GBS such as acupuncture, herbal medicine, moxibustion, and cupping have been reported, and some included Western medication. Herbal medicine and acupuncture were the most frequently used treatment methods. The most common prescription for GBS was Shipjeondaebotang Gami, the most common herb used was Glycyrrhizae radix et rhizome, and the most common acupoints were ST36, LI11, TE5, and LI4. In moxibustion treatment for GBS, CV4 was commonly used, and in cupping treatment the low back and back-shu points and were mostly used. Further studies on Korean medicine treatment of GBS are necessary for standardization of treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Analysis of Research Trends in Korean Medicine Treatment for Guillain-Barre Syndrome in Korea

Jang

Kim

et al. 2022

J Acupunct Res

View full text Add to dashboard Cite

show abstract

“…[18][19][20][21][22][23] In Korea, SYSADOA has been approved and is widely used in patients with OA. 24 Various herbal SYSDOAs are approved in Korea: JOINS TM , 25 LAYLA TM , 26 and SYNBARO TM , 27 as well as well-known SYSADOAs such as diacerein, avocado soybean unsaponifiable, and chondroitin. However, SYSADOAs have not been prescribed for KOA in Japan because they have not been approved.…”

Section: Discussionmentioning

confidence: 99%

International descriptive study for comparison of treatment patterns in patients with knee osteoarthritis between Korea and Japan using claims data

et al. 2019

View full text Add to dashboard Cite

Aim:To compare medication prescriptions for patients with knee osteoarthritis (KOA) in the real world in Korea and Japan.Methods: This retrospective and descriptive population-based study was conducted using claims data provided by Health Insurance Review and Assessment in Korea and JMDC Inc in Japan. We defined individuals as KOA patients if they had an International Classification of Diseases 10 (ICD10) code for gonarthrosis (M17) and were ≥50 years old in 2012. Korean and Japanese patients were matched for age and sex using frequency matching. Patients were observed for 1 year from the first month of the ICD10 code M17 in 2012. We described baseline characteristics including prevalence of comorbidities, and use of medication for KOA during the observational period. Results:The median age was 59 and the percentage of women was 61.4 in both countries (N = 1 133 138 in Korea, N = 10 498 in Japan). The prevalence of nonsteroidal anti-inflammatory drug (NSAID) usage in Japan (74.7%) was significantly higher than that in Korea (59.0%). Analgesics such as acetaminophen and symptomatic slow-acting drugs for OA (SYSADOA) were significantly more frequently used in Korea (25.8%) than in Japan (9.4%). Intra-articular injection (IAI) of corticosteroids or hyaluronic acid was performed more frequently in Japanese patients (57.3%) than Korean patients (30.5%). Conclusions:Medication patterns for KOA in Korea and Japan are described for the first time. Use of NSAIDs and IAI were more common in Japan, while other pain killers and SYSADOA were more commonly prescribed in Korea. K E Y W O R D S epidemiology, osteoarthritis, therapeutics S U PP O RTI N G I N FO R M ATI O N Additional supporting information may be found online in the Supporting Information section. How to cite this article: Sakai R, Cho S-K, Jang EJ, Harigai M, Sung Y-K. International descriptive study for comparison of treatment patterns in patients with knee osteoarthritis between Korea and Japan using claims data. Int J Rheum Dis.

show abstract

“…Eucommiae Cortex (EC), which is the dried stem bark of Eucommia ulmoides Oliver (Eucommiaceae), has been used as a traditional medicine in Korea for its antihypertensive, anti-inflammatory, antiviral, kidney-invigorating, and hepatoprotective activities, which it achieves without side effects [25][26][27] . In particular, as a component of mixed herbal formulations, EC has been reported to have anti-arthritic effects 28,29) . Achyranthis Radix (AR), the dried roots of Achyranthes bidentata Blume, is an important traditional Korean medicine that is used extensively by medical practitioners to treat osteodynia of the lumbar region and knees, spasms, and flaccidity of the limbs 30) .…”

Section: Introductionmentioning

confidence: 99%

Selection of the optimal herbal composition of pomegranate concentrated powder from aqueous extracts of and to treat osteoarthritis in rats

Choi¹,

Kang

et al. 2017

J Korean Med

View full text Add to dashboard Cite

We investigated whether a mixture of the main component of pomegranate concentrated powder (PCP) with appropriate proportions of Eucommiae Cortex (EC) and Achyranthis Radix (AR) could act synergistically as an effective treatment for osteoarthritis (OA). Methods: In order to evaluate the effects of PCP, EC, and AR against OA, knee thicknesses, maximum extension angle of each knee, antiinflammation effects, the transcript levels of chondrogenic genes mRNA expressions in femur and tibia articular cartilage (AC) with synovial membrane (SM) were analyzed. In addition, the histopathology and immunohistochemistry of the femur and tibia AC or SM were performed. Results: The surgically-induced OA signs in rats were significantly inhibited by 28 days of continuous treatment of PCP, EC and AR single formulas, and PCP with EC:AR mixed formulas. Especially, PCP with EC:AR 4:1, 2:1 and 1:1 mixed formula treatment constantly showed significantly more favorable inhibitory activities, as compared with those of single formula of PCP, EC and AR treated rats. Conclusion: PCP and EC:AR 4:1 mixed formula showed similar OA refinement effects through potent anti-inflammatory pathways as compared with those of diclofenac treatment, and showed additional chondrocyte proliferating effects on the both femur and tibia AC.

show abstract

Erratum to: SHINBARO, a new herbal medicine with multifunctional mechanism for joint disease: First therapeutic application for the treatment of osteoarthritis

Cited by 8 publications

References 0 publications

Analysis of Research Trends in Korean Medicine Treatment for Guillain-Barre Syndrome in Korea

Analysis of Research Trends in Korean Medicine Treatment for Guillain-Barre Syndrome in Korea

International descriptive study for comparison of treatment patterns in patients with knee osteoarthritis between Korea and Japan using claims data

Selection of the optimal herbal composition of pomegranate concentrated powder from aqueous extracts of and to treat osteoarthritis in rats

Contact Info

Product

Resources

About